Centagenetix (A): Building a Business Model for Genetic Longevity

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Case

Reference no. 9-602-087

Subject category: Production and Operations Management

Authors: Frank Angella (Harvard Business School); Henry W Chesbrough (Harvard Business School)

Published by: Harvard Business Publishing

Originally published in: 2001

Version: 12 June 2002

Length: 23 pages

Data source: Field research

Topics: Biotechnology; Intellectual property (IP); Licenses

Share a link: https://casecent.re/p/41451

| No reviews for this item

This product has not been used yet

View our pricing guide or login to see prices.

Abstract

Describes a start-up company seeking to exploit population genetic data from long-lived, healthy people. The company must address legal, financial, ethical, and personal issues among its team to launch the company.; Illustrates complexities of taking medical research out to the market and the conflicts that arise.

Location:

Boston, MA

Industry:

Bio-technology

Size:

Start-up

Other setting(s):

2001